Christopher A. Benetatos

2.9k total citations · 2 hit papers
18 papers, 2.1k citations indexed

About

Christopher A. Benetatos is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Christopher A. Benetatos has authored 18 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Immunology. Recurrent topics in Christopher A. Benetatos's work include Cell death mechanisms and regulation (8 papers), Ubiquitin and proteasome pathways (6 papers) and interferon and immune responses (4 papers). Christopher A. Benetatos is often cited by papers focused on Cell death mechanisms and regulation (8 papers), Ubiquitin and proteasome pathways (6 papers) and interferon and immune responses (4 papers). Christopher A. Benetatos collaborates with scholars based in United States, Australia and Switzerland. Christopher A. Benetatos's co-authors include John Silke, Stephen M. Condon, Srinivas K. Chunduru, W. Wei‐Lynn Wong, James E. Vince, David L. Vaux, Nufail Khan, Mark A. McKinlay, Diep Chau and Robert Brink and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

Christopher A. Benetatos

18 papers receiving 2.0k citations

Hit Papers

IAP Antagonists Target cI... 2007 2026 2013 2019 2007 2015 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher A. Benetatos United States 13 1.6k 823 482 364 254 18 2.1k
Xuefeng Wu United States 25 1.2k 0.7× 953 1.2× 684 1.4× 445 1.2× 268 1.1× 42 2.0k
Junming Yie United States 16 1.7k 1.1× 873 1.1× 467 1.0× 460 1.3× 208 0.8× 21 2.5k
Soizic Daniel United States 24 684 0.4× 619 0.8× 296 0.6× 165 0.5× 161 0.6× 36 1.4k
Hannah Nguyen Canada 18 1.1k 0.7× 1.3k 1.5× 414 0.9× 1.1k 3.0× 242 1.0× 22 2.5k
C L Verweij Netherlands 25 757 0.5× 1.3k 1.6× 540 1.1× 456 1.3× 159 0.6× 33 2.9k
Robin Humphreys United States 29 1.5k 0.9× 461 0.6× 367 0.8× 903 2.5× 188 0.7× 55 2.2k
Guanhua Song China 19 829 0.5× 516 0.6× 386 0.8× 284 0.8× 139 0.5× 43 1.4k
Xin‐Yuan Fu United States 19 1.6k 1.0× 1.5k 1.8× 540 1.1× 1.8k 4.8× 177 0.7× 34 3.2k
Roshan J. Thapa United States 15 1.2k 0.8× 885 1.1× 228 0.5× 262 0.7× 290 1.1× 19 1.7k
Keishi Fujiwara Japan 21 983 0.6× 316 0.4× 248 0.5× 319 0.9× 840 3.3× 38 2.0k

Countries citing papers authored by Christopher A. Benetatos

Since Specialization
Citations

This map shows the geographic impact of Christopher A. Benetatos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher A. Benetatos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher A. Benetatos more than expected).

Fields of papers citing papers by Christopher A. Benetatos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher A. Benetatos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher A. Benetatos. The network helps show where Christopher A. Benetatos may publish in the future.

Co-authorship network of co-authors of Christopher A. Benetatos

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher A. Benetatos. A scholar is included among the top collaborators of Christopher A. Benetatos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher A. Benetatos. Christopher A. Benetatos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Tanzer, Maria C., Nufail Khan, James Rickard, et al.. (2017). Combination of IAP antagonist and IFNγ activates novel caspase-10- and RIPK1-dependent cell death pathways. Cell Death and Differentiation. 24(3). 481–491. 38 indexed citations
2.
Lawlor, Kate E., Nufail Khan, Motti Gerlic, et al.. (2015). RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKL. Nature Communications. 6(1). 6282–6282. 510 indexed citations breakdown →
3.
Kapoor, Gurpreet S., Christopher A. Benetatos, Yasuhiro Mitsuuchi, et al.. (2014). Abstract 2278: The SMAC-mimetic birinapant regulates autocrine TNF production by caspase-8:RIPK1 complex via p38MAPK pathway. Cancer Research. 74(19_Supplement). 2278–2278. 1 indexed citations
4.
Krepler, Clemens, Srinivas K. Chunduru, Molly B. Halloran, et al.. (2013). The Novel SMAC Mimetic Birinapant Exhibits Potent Activity against Human Melanoma Cells. Clinical Cancer Research. 19(7). 1784–1794. 79 indexed citations
5.
Kapoor, Gurpreet S., Brian Geier, Eric M. Neiman, et al.. (2013). Abstract 599: Potential biomarkers of Smac mimetic tumor sensitivity: inhibitor of apoptosis protein DNA copy number.. Cancer Research. 73(8_Supplement). 599–599. 1 indexed citations
6.
Mitsuuchi, Yasuhiro, Stephen M. Condon, Eric M. Neiman, et al.. (2013). Abstract 3333: Birinapant, a novel bivalent Smac mimetic drug, is superior to monovalent Smac mimetics in inhibition of NF-kB by targeting TRAF2-bound cIAP1 and cIAP2.. Cancer Research. 73(8_Supplement). 3333–3333. 1 indexed citations
7.
Darding, Maurice, Rebecca Feltham, Tencho Tenev, et al.. (2011). Molecular determinants of Smac mimetic induced degradation of cIAP1 and cIAP2. Cell Death and Differentiation. 18(8). 1376–1386. 81 indexed citations
8.
Jackson, Randy W., Matthew G. LaPorte, Torsten Herbertz, et al.. (2011). The discovery and structure–activity relationships of pyrano[3,4-b]indole-based inhibitors of hepatitis C virus NS5B polymerase. Bioorganic & Medicinal Chemistry Letters. 21(11). 3227–3231. 17 indexed citations
9.
Graham, Martin A., Jennifer Burns, Srinivas K. Chunduru, et al.. (2011). Abstract A25: Phase 1 PK/PD analysis of the Smac-mimetic TL32711 demonstrates potent and sustained cIAP1 suppression in patient PBMCs and tumor biopsies.. Molecular Cancer Therapeutics. 10(11_Supplement). A25–A25. 5 indexed citations
10.
LaPorte, Matthew G., Charles W. Blackledge, Lara K. Leister, et al.. (2010). The discovery and structure–activity relationships of pyrano[3,4-b]indole based inhibitors of hepatitis C virus NS5B polymerase. Bioorganic & Medicinal Chemistry Letters. 20(9). 2968–2973. 33 indexed citations
11.
Griffith, Thomas S., Tamara A. Kucaba, Michael A. O’Donnell, et al.. (2010). Sensitization of human bladder tumor cells to TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis with a small molecule IAP antagonist. APOPTOSIS. 16(1). 13–26. 25 indexed citations
12.
Vince, James E., Diep Chau, Bernard A. Callus, et al.. (2008). TWEAK-FN14 signaling induces lysosomal degradation of a cIAP1–TRAF2 complex to sensitize tumor cells to TNFα. The Journal of Cell Biology. 182(1). 171–184. 209 indexed citations
13.
Vince, James E., Diep Chau, Bernard A. Callus, et al.. (2008). TWEAK-FN14 signaling induces lysosomal degradation of a cIAP1–TRAF2 complex to sensitize tumor cells to TNFα. The Journal of Experimental Medicine. 205(8). i18–i18. 1 indexed citations
14.
Vince, James E., W. Wei‐Lynn Wong, Nufail Khan, et al.. (2007). IAP Antagonists Target cIAP1 to Induce TNFα-Dependent Apoptosis. Cell. 131(4). 682–693. 879 indexed citations breakdown →
15.
Yang, Guang, Daniel C. Pevear, Marc S. Collett, et al.. (2004). Newly Synthesized Hepatitis C Virus Replicon RNA Is Protected from Nuclease Activity by a Protease-Sensitive Factor(s). Journal of Virology. 78(18). 10202–10205. 15 indexed citations
16.
Baginski, Scott G., Daniel C. Pevear, Christopher A. Benetatos, et al.. (2000). Mechanism of action of a pestivirus antiviral compound. Proceedings of the National Academy of Sciences. 97(14). 7981–7986. 89 indexed citations
17.
Ranganathan, Sulabha, et al.. (1998). Cloning and sequencing of human βIII-tubulin cDNA: induction of βIII isotype in human prostate carcinoma cells by acute exposure to antimicrotubule agents. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1395(2). 237–245. 42 indexed citations
18.
Ranganathan, Sulabha, Hernando Salazar, Christopher A. Benetatos, & Gary R. Hudes. (1997). Immunohistochemical analysis of β-tubulin isotypes in human prostate carcinoma and benign prostatic hypertrophy. The Prostate. 30(4). 263–268. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026